Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL378P is a human pseudogene of the non-coding RNA family, specifically derived from the 7SL RNA component of the signal recognition particle (SRP)[1][4][7]. Pseudogenes like RN7SL378P are non-functional segments of DNA that resemble functional genes but are typically not transcribed or translated into functional products[4][6]. Some pseudogenes in the human genome show evidence of regulatory activity, such as acting as ceRNAs to modulate parental gene expression, or as sources of small RNAs (sRNAs) with epigenetic regulatory roles[2][6]. However, there is no evidence that RN7SL378P itself is transcribed or plays a functional or regulatory role. Its parental gene, 7SL RNA (RN7SL1), is well-characterized as an essential structural RNA in the SRP complex, mediating the cotranslational targeting of proteins to the endoplasmic reticulum and involved in broader roles including immune signaling and disease[3][5]. RN7SL378P, as a pseudogene, does not retain these functions. Key distinctions: - RN7SL378P is not a therapeutic target or biomarker. - It is a member of the pseudogene class of non-coding RNAs. - Detailed functional, disease, or drug interaction roles pertain to the parental RN7SL1 gene, not the pseudogene RN7SL378P[1][3][5][7]. RN7SL378P should not be considered a canonical drug target or therapeutic biomarker until more evidence is available regarding functional roles for such pseudogenes in human biology and disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 378, pseudogene (RN7SL378P).